Clinical Trial Update: Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating daily oral paltusotine for carcinoid syndrome is currently recruiting, with several carcinoid-related indications listed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome
• Carcinoid Tumor of Cecum
• Carcinoid Tumor of Ileum
• Carcinoid Tumor of Liver
• Carcinoid Tumor of Pancreas

Drugs mentioned

• Paltusotine (paltusotine)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Carcinoid Syndrome, Carcinoid | Phase 3 | Status: RECRUITING